▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Simon Erickson

XMFInnovator

I am a believer in the power of disruptive innovation, and that individual investors can significantly outperform the market over long periods of time. I am the lead advisor of our Motley Fool Explorer service, where we look for future-focused companies well-poised to capitalize on developing long-term trends.

Recent Articles by Simon Erickson

Jun 23, 2014 by Simon Erickson

Stocks on Our Radar: SolarCity

In this edition of our new Stocks on Our Radar feature, analysts Simon Erickson and Sara Hov take a look at SolarCity.

Jun 13, 2014 by Simon Erickson

Stocks on Our Radar: Lululemon

In this week's episode of our new 'Stocks on Our Radar' series, analyst Simon Erickson takes a look at Lululemon.

Jun 10, 2014 by Simon Erickson

3 Innovative Companies to Keep an Eye On

If you're a fan of innovation, Amazon, Tesla, and Samsung have all been in the news lately with big developments. But what does their latest thinking mean for investors?

Jun 7, 2014 by Simon Erickson and Jason Moser

Stocks on Our Radar: Yelp

In this edition of our new "Stocks on Our Radar" series, analysts Simon Erickson and Jason Moser take a look at YELP and XOOM.

May 30, 2014 by Simon Erickson and Sara Hov

Stocks on Our Radar: 3D Systems

In this edition of our brand-new "Stocks on Our Radar" series, analysts Simon Erickson and Sara Hov take a look at 3D Systems.

Apr 29, 2014 by Simon Erickson

3 Things Investors Have to Watch at ExOne Co.

ExOne's stock price has gotten hammered due to a recent sell-off in the 3-D printing industry. Is there light at the end of the tunnel for investors?

Apr 5, 2014 by Simon Erickson

Want to Print Profits? Here's a 3-D Printing Industry Checklist

We continue our series on checklists by taking a look at the 3-D printing industry.

Apr 1, 2014 by Simon Erickson

Pharmacy Benefit Management: Your Prescription for More Profits

We continue our series on checklists by taking a look at the Pharmacy Benefit Management industry.

Mar 24, 2014 by Simon Erickson

Better Buy: 3D Systems vs. Universal Display

We've collected the most popular companies amongst Fool.com readers and put them head to head in a good old-fashioned challenge we're calling The Motley Fool Better Buy Tournament.

Mar 22, 2014 by Simon Erickson and David Hanson

Better Buy: Stratasys vs. Prospect Capital

We've collected the most popular companies amongst Fool.com readers and put them head-to-head in a good old-fashioned challenge we're calling The Motley Fool Better Buy Tournament.

Mar 21, 2014 by Simon Erickson and Jamal Carnette, CFA

Better Buy: Tesla vs. CalAmp

We've collected the most popular companies among Fool.com readers and put them head-to-head in a good old-fashioned challenge we're calling The Motley Fool Better-Buy Tournament.

Mar 20, 2014 by Simon Erickson and Dave Williamson

Better Buy: Universal Display vs. Merck

We've collected the most popular companies among Fool.com readers and put them head to head in a good old-fashioned challenge we're calling The Motley Fool Better-Buy Tournament.

Mar 19, 2014 by Simon Erickson and Max Macaluso

Better Buy: Biogen vs. Stratasys

We've collected the most popular companies among Fool.com readers, and put them head-to-head in a good old-fashioned challenge we're calling The Motley Fool Better Buy Tournament.

Jan 28, 2014 by Simon Erickson

Ask a Fool: What Stock Are You Most Bullish On Right Now?

Rule Breakers analyst Simon Erickson explains why he is bullish on recently-public Veeva Systems.

Jan 27, 2014 by Simon Erickson

Ask a Fool: Where is Fuel Cell Technology Headed?

Rule Breakers analyst Simon Erickson takes a look at a recent winner in fuel cell technology.

Jan 12, 2014 by Simon Erickson

How Will New OLED TVs Shake Things Up in 2014?

The Consumer Electronics Show in Las Vegas introduced some exciting new products for your living room. How should we play this technology trend as investors?

Dec 30, 2013 by Simon Erickson

3 Growth Stocks for 2014

2013 was a great year for investors. Find out how 2014 can be even better.

Dec 10, 2013 by Simon Erickson and Max Macaluso

Will MannKind Inhale Novo Nordisk's Profits?

With a revolutionary new product set to launch in 2014, could MannKind disrupt the diabetes care market?

Dec 10, 2013 by Simon Erickson and Max Macaluso

3 Reasons Veeva Systems Should Be on Your Watchlist

After an IPO in October, cloud-based Veeva Systems looks poised to outperform.

Nov 25, 2013 by Simon Erickson and Max Macaluso

Is Novo Nordisk Still an Attractive Investment?

Despite a bumpy 2013, largely caused by the FDA rejection of its drug Tresiba, is Novo Nordisk a stock to add to your watchlist?

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services